Literature DB >> 33760993

Does Choice of Steroid Matter for Treatment of Chronic Low Back Pain with Sacroiliac Joint Injections: a Retrospective Study.

Ramya Krishnan1, Viji Kurup1, Nalini Vadivelu1, Feng Dai1, Bin Zhou1, Kanishka Rajput2.   

Abstract

PURPOSE OF REVIEW: Prevalence of chronic low back pain (cLBP) is increasing. Sacroiliac joint (SIJ) is a common source of cLBP, but data behind its diagnosis and treatment is controversial. There is moderate quality evidence for effectiveness of therapeutic SIJ injections. However, there are no studies comparing the two most common steroid preparations, methylprednisolone (MTP) and triamcinolone (TAC) in SIJ injections. RECENT
FINDINGS: After institutional IRB approval, a retrospective chart review was conducted to evaluate the effectiveness of SIJ injections in terms of pain relief at 1-month follow-up and compare MTP versus TAC. All injections were performed by a single pain physician with fluoroscopic guidance.
RESULTS: Sixty-five percent of patients in the MTP group and 57% patients in the TAC group had >50% pain relief at 1-month follow-up, with no statistical difference between the two groups. Patients in the TAC group had significantly greater BMI and consisted of higher proportion of smokers (72% patients in TAC group versus 39% patients in the MTP group, p-value 0.004). Other sources of pain such as facet joints were unmasked post-procedurally after SIJ injections, with this unmasking being significant for the TAC group. Opiate use decreased in the MTP group from 35% pre-procedurally to 20% post-procedurally, and this difference did not reach statistical significance. Both MTP and TAC are effective in providing pain relief for SIJ pain at 1-month follow-up, with no statistical difference between the two types of steroids. Although not statistically significant, there is a modest reduction in opiate use in the MTP group.

Entities:  

Keywords:  Chronic low back pain treatment; Methylprednisolone versus triamcinolone; SI joint injections; Sacroiliac joint steroid injections

Year:  2021        PMID: 33760993     DOI: 10.1007/s11916-021-00942-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  7 in total

1.  Diagnosis of sacroiliac joint pain: validity of individual provocation tests and composites of tests.

Authors:  Mark Laslett; Charles N Aprill; Barry McDonald; Sharon B Young
Journal:  Man Ther       Date:  2005-08

2.  Efficacy of sacroiliac corticosteroid injections in patients with inflammatory spondyloarthropathy: results of a 6 month controlled study.

Authors:  J G Hanly; M Mitchell; L MacMillan; D Mosher; E Sutton
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

Review 3.  Sacroiliac joint pain: a comprehensive review of epidemiology, diagnosis and treatment.

Authors:  Steven P Cohen; Yian Chen; Nathan J Neufeld
Journal:  Expert Rev Neurother       Date:  2013-01       Impact factor: 4.618

4.  Comparison between intraarticular triamcinolone acetonide and methylprednisolone acetate injections in treatment of frozen shoulder.

Authors:  Riyadh A Sakeni; Marwan S M Al-Nimer
Journal:  Saudi Med J       Date:  2007-05       Impact factor: 1.484

5.  Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint.

Authors:  E J Valtonen
Journal:  Scand J Rheumatol Suppl       Date:  1981

Review 6.  Systemic effects of intra-articular corticosteroids.

Authors:  George S Habib
Journal:  Clin Rheumatol       Date:  2009-02-28       Impact factor: 2.980

7.  Increase of chronic low back pain prevalence in a medium-sized city of southern Brazil.

Authors:  Rodrigo D Meucci; Anaclaudia G Fassa; Vera Mv Paniz; Marcelo C Silva; David H Wegman
Journal:  BMC Musculoskelet Disord       Date:  2013-05-01       Impact factor: 2.362

  7 in total
  1 in total

1.  Intradiscal injection for the management of low back pain.

Authors:  Fu Zhang; Songjuan Wang; Baoliang Li; Wei Tian; Zhiyu Zhou; Shaoyu Liu
Journal:  JOR Spine       Date:  2021-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.